The first NGS system was approved for clinical use by the FDA only in 2013. Hence, the market segment is quite new, even though a significant industry exists for LDTs performed as testing services on NGS platforms by certified clinical labs. The current IVD market available in clinical sequencing consists largely of sales of NGS […]

The market for medical devices is valued at $570 billion in 2022, according to Kalorama Information’s 12th report on the market since 2009. It grew 2.7% last year, and Kalorama believes it will grow average 3.4% next five years. Expect increasing revenue growth for 2022 as markets continue to stabilize. In 2023 and forward, growth […]

According to Kalorama Information’s 2022 molecular diagostics report [https://kaloramainformation.com/product/the-world-market-for-molecular-diagnostics-tests-11th-edition/], the market now exceed 21 billion. The demand for molecular IVD means that very often a single firm cannot go it alone and must find partners. These are partnerships involving 20 companies that have just occurred in recent months: Immucor and Pirche: a multi-year partnership to […]

Per a recent Kalorama Information report, In Vitro Diagnostics (IVD) in Malaysia, Singapore and Indonesia, 2022 (https://kaloramainformation.com/product/in-vitro-diagnostics-ivd-in-malaysia-singapore-and-indonesia-2022/). The market for IVDs in the three countries combined exceeds $1.9 billion dollars. This includes clinical tests for infectious disease, hematology, basic bloodwork, glucose and other conditions. The impact of COVID-19 in the microbiology and virology markets has […]